Parkside Financial Bank & Trust’s bluebird bio BLUE Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-85	Closed	-$415	–	2764
2025 Q1	$415	Buy	+85	New	+$511	﹤0.01%	2521
2021 Q4	–	Sell	-8	Closed	-$2K	–	1806
2021 Q3	$2K	Hold	8	–	–	﹤0.01%	1519
2021 Q2	$3K	Hold	8	–	–	﹤0.01%	1397
2021 Q1	$3K	Buy	+8	New	+$3.94K	﹤0.01%	1349

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parkside Financial Bank & Trust's BLUE Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 85 shares — an estimated $415 sold.

Parkside Financial Bank & Trust first reported a position in BLUE in Q1 2021 and held it in 4 quarters. The position peaked at $3K in Q2 2021. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Parkside Financial Bank & Trust reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Parkside Financial Bank & Trust sold 85 bluebird bio shares in Q2 2025, an estimated $415.
Parkside Financial Bank & Trust first reported a position in bluebird bio in Q1 2021 and held it in 4 quarters.
Parkside Financial Bank & Trust's bluebird bio position peaked at $3K in Q2 2021.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.